Jia, Y., Song, Y., Dong, G., Hao, C., Zhao, W., Li, S., & Tong, Z. (2019). Aberrant Regulation of RAD51 Promotes Resistance of Neoadjuvant Endocrine Therapy in ER-positive Breast Cancer. Sci Rep.
Chicago Style CitationJia, Yan, Yueshuai Song, Guolei Dong, Chunfang Hao, Weipeng Zhao, Shufen Li, i Zhongsheng Tong. "Aberrant Regulation of RAD51 Promotes Resistance of Neoadjuvant Endocrine Therapy in ER-positive Breast Cancer." Sci Rep 2019.
Cita MLAJia, Yan, et al. "Aberrant Regulation of RAD51 Promotes Resistance of Neoadjuvant Endocrine Therapy in ER-positive Breast Cancer." Sci Rep 2019.
Atenció: Aquestes cites poden no estar 100% correctes.